STORM Therapeutics

Cambridge, United Kingdom · Founded 2015 · Privately Held (backing)

Operator of a biotechnology and drug discovery company intended to develop small molecule therapies for RNA modification enzymes for use in the treatment of cancer and other immune diseases. STORM Therapeutics is based in Cambridge, United Kingdom and was founded in 2015. Its last reported valuation was $90.3 million in Dec 2022. It has raised $172 million.

Last reported valuation
$90.3M
Oct 2026
Priced at
—
Total raised
$172.2M
Last round
—

Who backs STORM Therapeutics?

12 investors
InvestorType
Innovate UKOther
Cambridge Enterprise VenturesVenture capital
M VenturesVenture capital
UTokyo Innovation Platform CompanyOther
Pfizer VenturesOther
Cambridge Innovation CapitalVenture capital
Cancer Research Horizons—
Fast Track Initiative—
IP Group—
Seroba Life Sciences—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

STORM Therapeutics investors

12 investors are on record for STORM Therapeutics, including Innovate UK, Cambridge Enterprise Ventures, M Ventures and UTokyo Innovation Platform Company.

Free account
More of STORM Therapeutics with a free account
  • ·The complete investor list: 12 names
  • ·Watch STORM Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like STORM Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View